Platelet-activating factor acetylhydrolase is not associated with carotid intima-media thickness in
Salvatore Campo1, Maria A Sardo, Alessandra Bitto
1Department of Internal Medicine and Institute of Statistical Science, School of Medicine, University of Messina, Messina, Italy.
Insights
Platelet-activating factor acetylhydrolase (PAF-AH) gene variants do not appear to influence PAF-AH activity or atherosclerosis in hypercholesterolemic individuals. This study found no significant differences in PAF-AH polymorphisms related to carotid artery intima-media thickness.
Area of Science:
- Cardiovascular Genetics
- Molecular Biology
- Biochemistry
Background:
- Atherosclerosis is a complex chronic disease influenced by factors like hypertension, hyperlipidemia, and oxidized LDL.
- Platelet-activating factor acetylhydrolase (PAF-AH) is an enzyme that hydrolyzes PAF and prevents LDL oxidation, potentially delaying atherosclerosis.
Purpose of the Study:
- To investigate the association between specific PAF-AH gene polymorphisms (Arg92His, Ile198Thr, Ala379Val) and carotid atherosclerosis.
- To determine if these polymorphisms affect PAF-AH activity and intima-media thickness in hypercholesterolemic individuals.
Main Methods:
- Studied 190 hypercholesterolemic Sicilian individuals.
- Measured carotid artery intima-media wall thickness (IMT) as an indicator of atherosclerosis.
- Analyzed PAF-AH gene polymorphisms, PAF-AH activity, and various clinical and biochemical parameters.
Main Results:
- A significant correlation was found between PAF-AH activity and LDL concentrations in hypercholesterolemic patients.
- No significant differences in PAF-AH gene polymorphisms were detected between groups with normal and abnormal IMT after adjusting for confounding factors.
- Plasma PAF-AH activity did not significantly correlate with HDL levels in either IMT group.
Conclusions:
- The study found no evidence that the investigated PAF-AH gene polymorphisms influence PAF-AH activity or the presence of atherosclerosis.
- These findings suggest that PAF-AH polymorphisms may not be significant determinants of atherosclerosis in this hypercholesterolemic population.
Background:
Atherosclerosis is a complex, chronic disease that usually arises from the converging action of several pathogenic processes, including hypertension, hyperlipidemia, obesity, and the accumulation of oxidized LDL. Platelet-activating factor acetylhydrolase (PAF-AH) is a LDL- and HDL-bound enzyme that hydrolyzes and inactivates PAF and prevents LDL-cholesterol oxidation, thus delaying the onset of atherosclerotic disease.
Methods:
We evaluated the relationship between variants of the PAF-AH gene polymorphisms Arg92His, Ile198Thr, and Ala379Val and the presence of carotid atherosclerosis in 190 hypercholesterolemic Sicilian individuals. Carotid artery intima-media wall thickness (IMT) was measured as an indicator of early atherosclerotic disease. The participants were classified according to having normal (< or =1 mm) or abnormal (> or =1 mm) IMT and were also investigated for physical characteristics and biochemical indices, including PAF-AH activity.
Results:
PAF-AH activity and LDL concentrations were significantly correlated in hypercholesterolemic patients, but plasma PAF-AH activity and HDL were not significantly correlated in either IMT group. No significant differences were detected among the PAF-AH gene polymorphisms in both groups after correction for age, sex, body mass index, plasma glucose and lipid concentrations, PAF-AH activity, blood pressure, and smoking habits. The analysis of PAF-AH genotype distribution showed no significant differences in percentage of 92, 198, and 379 genotypes in both IMT groups.
Conclusion:
Our data provided no evidence that PAF-AH polymorphisms influence PAF-AH activity and atherosclerosis in hypercholesterolemic Sicilian patients.
Related Concept Videos
Atherosclerosis I: Introduction
Coronary Artery Disease II: Pathophysiology
Peripheral Artery Disease I: Introduction
Clot Retraction and Fibrinolysis
